BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2769 related articles for article (PubMed ID: 33735425)

  • 1. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current practices in naloxone prescribing upon hospital discharge.
    Punzal M; Santos P; Li X; Oyler DR; Hall AM
    J Opioid Manag; 2019; 15(5):357-361. PubMed ID: 31849026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.
    Mueller SR; Koester S; Glanz JM; Gardner EM; Binswanger IA
    J Gen Intern Med; 2017 Mar; 32(3):277-283. PubMed ID: 27798775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings.
    Wilson JD; Spicyn N; Matson P; Alvanzo A; Feldman L
    Subst Abus; 2016; 37(3):480-487. PubMed ID: 26820604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitudes and practices of Canadian pediatric emergency physicians regarding short-term opioid use: a descriptive, cross-sectional survey.
    Fowler M; Ali S; Gouin S; Drendel AL; Poonai N; Yaskina M; Sivakumar M; Jun E; Dong K;
    CMAJ Open; 2020; 8(1):E148-E155. PubMed ID: 32184278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
    Slevin KA; Ashburn MA
    J Opioid Manag; 2011; 7(2):109-15. PubMed ID: 21561034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A personalized protocol for prescribing opioids after cesarean delivery: leveraging the electronic medical record to reduce outpatient opioid prescriptions.
    Imo CS; Macias DA; McIntire DD; McGuire J; Nelson DB; Duryea EL
    Am J Obstet Gynecol; 2024 Apr; 230(4):446.e1-446.e6. PubMed ID: 37778679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone Prescribing in an Academic Emergency Department: Provider Practices and Attitudes.
    Hernandez-Meier J; Li D; Zosel A
    WMJ; 2023 Mar; 122(1):20-25. PubMed ID: 36940117
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 139.